Company attributes
CEO
Founder
AngelList URL
Pitchbook URL
Legal Name
Concert Pharmaceuticals, Inc.
Legal classification
Date Incorporated
2006
Number of Employees (Ranges)
51 – 200
Email Address
info@concertpharma.com0
Phone Number
+178186000450
Full Address
65 HAYDEN AVENUE, STE. 3000N LEXINGTON, 02421 MA USA0
CIK Number
Investors
DUNS Number
7931756180
Founded Date
2006
Total Funding Amount (USD)
129,500,000
Latest Funding Round Date
June 2017
Stock Symbol
CNCE0
Exchange
Board of Directors
Acquisition Transaction
Latest Funding Type
NAICS Code
325,4120
CAGE Code
62GN10
Patents Assigned (Count)
131
Wellfound ID
Country
Other attributes
Company Operating Status
Active
SIC Code
2,8340
Ticker Symbol
CNCE
Wikidata ID
Concert Pharmaceuticals is a company that is pioneering the deuterium chemistry usage, for discovering and developing innovative new medicines that positively makes impact on patient care and addresses important medical needs.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
